Wellgistics Health (WGRX) Cash & Equivalents (2023 - 2026)

Wellgistics Health has reported Cash & Equivalents for 4 years, with the latest figure at $51730.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 97.94% year-over-year to $51730.0; the trailing twelve-month figure through Mar 2026 stood at $51730.0 (down 97.94% YoY), and the FY2025 full-year result was $42571.0, down 95.86% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $51730.0, up from $42571.0 in the prior quarter.
• The five-year high for Cash & Equivalents was $4.2 million in Q3 2025, with the low at $1364.0 in Q4 2023.
• Historically, Cash & Equivalents has averaged $1.2 million across 4 years, with a median of $419942.0 in 2025.
• Annual changes were most pronounced in 2024 — Cash & Equivalents surged 75291.2% — and 2026, when it tumbled 97.94%.
• Wellgistics Health's Cash & Equivalents stood at $1364.0 in 2023, then surged by 75291.2% to $1.0 million in 2024, then sank by 95.86% to $42571.0 in 2025, then increased by 21.51% to $51730.0 in 2026.
• The last three Cash & Equivalents figures came in at $51730.0 (Q1 2026), $42571.0 (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.